SEC Filings

Filing date Description Form Filing Group View

Annual report which provides a comprehensive overview of the company for the past year

10-K
Annual Filings
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Securities offered to employees pursuant to employee benefit plans

S-8
Registration Statements
View HTML

Filing by person(s) reporting owned shares of common stock in a public company >5%

SC 13D
Other
View HTML

An amendment to a 3 filing. Non-EDGAR filing

3/A
3,4,5
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

An amendment to the SC 13G filing

SC 13G/A
Other
View HTML

An amendment to the SC 13G filing

SC 13G/A
Other
View HTML

Data provided by Kaleidoscope.

Top

External Link

You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Jasper Therapeutics is not responsible for 3rd party website content.